IP Library Assignment 029560/0697
Patent Assignment
Reel/Frame 029560/0697

Assignment of Assignor's Interest

Recorded: 2013-01-03 Pages: 4
Assignor
PURDUE PHARMA L.P.
Executed: 2012-12-20
Assignees
PURDUE PHARMA L.P.
ONE STAMFORD FORUM, 201 TRESSER BOULEVARD, STAMFORD, CONNECTICUT, 06901-3431
THE P.F. LABORATORIES, INC.
700 UNION BOULEVARD, TOTOWA, NEW JERSEY, 07512
PURDUE PHARMACEUTICALS L.P.
4701 PURDUE DRIVE, WILSON, NORTH CAROLINA, 27893
Covered Properties (2)
Pharmaceutical Formulation Containing Opioid Agonist,Opioid Antagonist and Gelling Agent
Patent: 7,842,307 →
Application: 10/214,413 →
Publication: US 2003/0068371
Pharmaceutical Formulations Containing Opioid Agonist, Opioid Antagonist and Gelling Agent
Patent: 8,524,275 →
Application: 12/909,527 →
Publication: US 2011/0230510
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 15, 2002
From: OSHLACK, BENJAMIN; WRIGHT, CURTIS; BREDER, CHRISTOPER
To: EURO-CELTIQUE S.A.
Reel/Frame 013387/0695 →
Assignment of Assignor's Interest Dec 7, 2007
From: EURO-CELTIQUE S.A.
To: PURDUE PHARMA L.P.
Reel/Frame 020226/0065 →
Assignment of Assignor's Interest Apr 17, 2019
From: THE P.F. LABORATORIES, INC.; PURDUE PHARMA TECHNOLOGIES, INC.
To: PURDUE PHARMA L.P.
Reel/Frame 048932/0651 →